Inhibition of tumor growth was accompanied by a reduction in anti-apoptotic Bcl-2, Bcl-XL, Mcl-1, survivin, and VEGF in tumor tissue, and decreased expression of proliferation mediators cyclin D and c-Myc. The gene discussed is BIRC5; the disease is neoplasm.